Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on the research, cultivation, manufacturing, and sale of breakthrough cannabis-based medicines, announces that further to the 6 June 2025 announcement, it
Roquefort Therapeutics shares jump 61% after an agreement to sell its subsidiary, Oncogeni.
Roquefort Therapeutics PLC (LON: ROQ) has agreed to sell its subsidiary, Oncogeni, to UAE-based Nations Trust Holding in a deal worth up to $12 million (£9.3 million).
Celadon Pharmaceuticals PLC (AIM:CEL) soared over 25% after finance update
Shares in Celadon Pharmaceuticals PLC (AIM: CEL), a UK-based pharmaceutical company specialising in cannabis-based medicines, surged over 25% in early trading following a financial update.
Roquefort Therapeutics plc (LSE:ROQ,OTCQB:ROQAF) Midkine Antibody Licencing Deal
Roquefort Therapeutics plc (LSE: ROQ, OTCQB: ROQAF), the Main Market listed biotech company focused on developing first in class medicines in the high value and high growth immuno-oncology market is pleased to announce
Redx Pharma is advancing with ts primary asset, RXC007
Redx Pharma PLC (AIM: REDX) announced that its primary asset, RXC007, is successfully moving through phase IIa testing, with anticipated results from the idiopathic pulmonary fibrosis research due in the
Redx Pharma plc (AIM:REDX) Collaboration with the Garvan Institute
Redx Announces Collaboration with the Garvan Institute of Medical Research
FastForward Inn Ltd (FFWD.L) Investment in cannabis healthcare company- CiiTECH
FastForward Innovations Ltd, (AIM:FFWD) the listed investor focused on fast-growing and industry leading businesses, is pleased to announce that it has participated in the £2.1 million issuance of Convertible Loan
FastForward Inn Ltd (FFWD.L) Investee Company Update: Little Green Pharma Ltd
FastForward Innovations Ltd, the AIM quoted company focusing on making investments in fast growing and industry leading businesses, is pleased to note the announcement by portfolio company Little Green Pharma
FastForward Inn Ltd (FFWD.L) Investee Company Update: Little Green Pharma
FastForward Innovations Ltd, the AIM-quoted company focusing on making investments in fast-growing and industry-leading businesses, is pleased to note that Little Green Pharma Ltd (‘LGP’) has announced an additional A$2.5m
FastForward Inn Ltd (FFWD.L) Completion of Sale of Investment in EMMAC
FastForward Innovations Ltd, the AIM quoted company focusing on making investments in fast growing and industry leading businesses, is pleased to note that, further to the announcement of 10 March
Destiny Pharma PLC (DEST.L) to Join Equity Development Webinar
Destiny Pharma to Join Equity Development Webinar on Positive Phase 2b Top-line Results for XF-73 Nasal Gel
FastForward Inn Ltd (FFWD.L) Corporate Update
FastForward Innovations Ltd, the AIM quoted company focusing on making investments in fast growing and industry leading businesses, is pleased to provide a corporate update prior to its financial year-end